Easthall Claire, Taylor Natalie, Bhattacharya Debi
School of Healthcare, University of Leeds, Leeds, West Yorkshire, UK.
Cancer Research Division, Cancer Council NSW, Woolloomooloo, Sydney, Australia.
Int J Pharm Pract. 2019 Jun;27(3):223-231. doi: 10.1111/ijpp.12491. Epub 2018 Oct 3.
To identify barriers to medication adherence in patients prescribed medicines for the prevention of cardiovascular disease and map these to the Theoretical Domains Framework (TDF), to produce a conceptual framework for developing a questionnaire-based medication adherence tool.
A scoping review of barriers to medication adherence in long-term conditions was conducted to generate an initial pool of barriers. After preliminary mapping to the TDF, these barriers were presented to two focus groups of patients prescribed medicines for the prevention of cardiovascular disease (n = 14) to stimulate discussion. The group discussions enabled the patients' interpretations of the adherence barriers to be determined, provided validity from the patient perspective and identified additional barriers unrepresented in the scoping review.
The preliminary pool of adherence barriers was identified from 47 studies across a range of long-term conditions. The majority of TDF domains were represented by these literature-identified barriers except 'social/professional role and identity' and 'behavioural regulation'. Barrier mapping was largely endorsed by focus group participants, who also contributed additional barriers, including those relating to not having a 'system' in place for managing their medicines and the negative emotions evoked by medicine taking.
The TDF enabled full exploration of adherence barriers including those relating to emotions which have received limited attention in the literature. This work has provided a conceptual framework for developing a questionnaire to identify an individual's adherence barriers which may then be coupled with appropriate behaviour change techniques to deliver a theory-based intervention tailored for individual need.
确定开具预防心血管疾病药物的患者在药物依从性方面的障碍,并将这些障碍对应到理论领域框架(TDF),以构建一个概念框架,用于开发基于问卷的药物依从性工具。
对长期疾病中药物依从性障碍进行了范围综述,以生成一个初始障碍库。在初步对应到TDF后,将这些障碍呈现给两个由开具预防心血管疾病药物的患者组成的焦点小组(n = 14),以激发讨论。小组讨论有助于确定患者对依从性障碍的理解,从患者角度提供有效性,并识别范围综述中未涵盖的其他障碍。
从47项针对一系列长期疾病的研究中确定了依从性障碍的初步库。除了“社会/职业角色与身份”和“行为调节”外,这些文献确定的障碍涵盖了大多数TDF领域。障碍对应在很大程度上得到了焦点小组参与者的认可,他们还提出了其他障碍,包括没有一个管理药物的“系统”以及服药引发的负面情绪。
TDF有助于全面探索依从性障碍,包括那些在文献中受到有限关注的与情绪相关的障碍。这项工作为开发一份问卷提供了一个概念框架,以识别个体的依从性障碍,然后可将其与适当的行为改变技巧相结合,以提供基于个体需求的理论干预。